419413
Position
Civilian Deputy to the Principal Assistant for Research & Technology
Location
FORT DETRICK MD UNITED STATES
Bio
Dr. Mark Dertzbaugh serves as the Civilian Deputy to the Principal Assistant for Research and Technology PA(R&T), US Army Medical Research and Materiel Command (USAMRMC), Fort Detrick, MD. Dr. Dertzbaugh entered civilian service in 1991 working as a mucosal immunologist at the US Army Medical Research Institute of Infectious Diseases (USAMRIID), where he performed research in several different areas related to vaccines. In 1996, Dr. Dertzbaugh became a Product Manager for the Joint Vaccine Acquisition Program (JVAP) where he managed the development program for the Venezuelan equine encephalitis virus vaccine before returning to USAMRIID to start a new research program in pulmonary immunology. Dr. Dertzbaugh served as the Chief of Business Plans & Programs at USAMRIID and was instrumental in facilitating a strategic initiative to restructure the Institute and improve internal processes related to research planning and management. Dr. Dertzbaugh received his B.S. in Biology from James Madison University in 1982 and his Ph.D. in Microbiology & Immunology from Virginia Commonwealth University in 1989. He completed his postdoctoral training at the University of Alabama at Birmingham in 1989. He has authored a number of peer-reviewed journal articles and is an inventor on several patents. Dr. Dertzbaugh has received several awards including the Commander’s Award for Civilian Service, the Army Achievement Medal, a Department of the Army Commendation for Exceptional Performance, and the Army Medical Department Order of Military Medical Merit.
Agenda
bio2018-mybio-sessionicon-session

9:00 AM–12:00 PM Jun 4, 2018

Room 205ABC, Level 2

Phyllis ArthurVice President, Infectious Diseases & Diagnostics Policy atBiotechnology Innovation Organization (BIO) Timothy BelskiJoint Product Lead for the Advanced Development & Manufacturing Capability atJoint Program Executive Office for Chemical and Biological Defense, Medical Countermeasure Systems Lt. Matthew ClarkJoint Product Manager, Chemical Defense Pharmaceuticals atMedical Countermeasure Systems Joseph CohnChief, Research Program Administration Division J9, Research & Development Directorate atDefense Health Agency Jennifer DabischJoint Product Lead for the Diagnostics Product management office atJoint Program Executive Office for Chemical and Biological Defense, Medical Countermeasure Syst Dr. Mark DertzbaughCivilian Deputy to the Principal Assistant for Research & Technology atU.S. Army Medical Research and Materiel Command Hannah FeldmanPublic Affairs Specialist atJoint Program Executive Office for Chemical and Biological Defense, Medical Countermeasure Systems Tom HandelGeneral Manager and President atMeridian Medical Technologies, Inc. Carl H.Chief Strategic Initiatives Officer atDoD Medical Countermeasure Systems Dr. David HoneChief Scientist, Vaccine and Therapeutic Division, Joint Science and Technology Office atDefense Threat Reduction Agency Nicole KilgoreJoint Product Lead for the Platforms for Rapid Integrated Solutions for Medical Countermeasures atJoint Program Executive Office for Chemical and Biological Defense, Medical Countermeasure Systems Lt. Col. Cindy Landgren, PhDDeputy, Medical Programs atOffice of Deputy Assistant Secretary of Defense, Chemical and Biological Defense Carmen MaherDirector, Medical Regulatory Affairs atJoint Program Executive Office for Chemical and Biological Defense Col. Nelson MichaelDeputy Commander atWalter Reed Army Institute of Research Dr. James PhillipsProjects Officer, Office of the Principal Assistant for Acquisitions atU.S. Army Medical Research and Materiel Command Dr. Jason Roos, PhDDeputy Program Executive Officer atJoint Program Executive Office for Chemical and Biological Defense Dr. Mike StebbinsConsortium Manager atAdvanced Technology International Col. Gary Wheeler, Commander, U.S. Army Medical Research Institute of Infectious Diseases atU.S. Army Medical Research and Materiel Command
Interests
None yet.